DOSSIER · UPDATED 18 NOV 2025

ROME Therapeutics

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug…

rometx.com ↗Claim this profile
Founded
2020
Headcount
67
Open roles
0
Last raised
Series B · $72M
SECTION I · THE BRIEF

Inside ROME Therapeutics

Brief #84563Updated 18 NOV 2025BOSTONGVSERIES B
Employbl Dossier

ROME Therapeutics

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.”…

Founded
2020
Headcount
67
Open roles
0
Last raised
Series B · $72M
Section II — RestrictedMembers only
  • Engineering interview process at ROME Therapeutics
  • Tech stack & infrastructure choices
  • Culture & day-to-day work style
  • Why join now vs. 6 months from now
  • Hiring focus & open headcount by team
  • Comp philosophy and band context
Open ROME Therapeutics briefSign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Rosana KapellerRosana Kapeller
David TingDavid Ting
Benjamin Greenbaum
Jay ParrishJay Parrish
OPEN ROLES

Hiring at ROME Therapeutics

Current Job Listings

Listing 0 of 0 job openings
We don't currently have any jobs listed for this company. We suggest visiting the Jobs Search page if you are looking for exciting new tech and startup opportunities.
FUNDING

Capital raised

Total Amount Raised: $199,000,000

ROME Therapeutics' Investors

ROME Therapeutics Funding Rounds

  • Series B

    $72,000,000

  • Series B

    $72,000,000

    Series B Investors

    Alexandria Venture Investments
    Sigmas Group
    Johnson & Johnson Innovation
    ArchVentures
    Bristol-Myers Squibb Company
    Andreessen Horowitz
    Axon Ventures
    Mirae Asset Capital
    Sanofi
    S32
    Casdin Capital
    Mass General Brigham
    Luma Group
    GV
    RS Participaties
    Eurofarma Ventures

  • Series B

    $77,000,000

  • Series B

    $77,000,000

    Series B Investors

    S32
    Sanofi
    Alexandria Venture Investments
    GV
    Arch Venture Partners
    Casdin Capital
    Andreessen Horowitz
    Mass General Brigham

  • Series A

    $50,000,000

  • Series A

    $50,000,000

    Series A Investors

    GV
    Partners Innovation Fund
    Arch Venture Partners
Funding info provided by Diffbot.
TAGS

Categorized in

Company Collections

These are collections ROME Therapeutics is a part of. Click on the collection name to view similar companies.

ROME Therapeutics' Investors

ROME Therapeutics' Industries

ROME Therapeutics' Tech Stack

Company Collections For ROME Therapeutics

LOCATIONS

Where they work

ROME Therapeutics Headquarters Location

201 Brookline Avenue, Boston, MA, 02215

Loading map…